Literature DB >> 24212478

A comparison of spinal anesthesia characteristics following intrathecal bupivacaine or levobupivacaine in lumbar disc surgery.

Ayça Sultan Şahin1, Gürkan Türker, Ahmet Bekar, Hülya Bilgin, Gülsen Korfalı.   

Abstract

PURPOSE: While bupivacaine is the most frequently used local anesthetic for spinal anesthesia, use of levobupivacaine in clinical practice has advanced recently. The aim of our study was to compare the clinical and anesthetic effects of isobaric bupivacaine and isobaric levobupivacaine when administered intrathecally in patients undergoing lumbar disc surgery.
METHODS: ASA I-III, 60 patients were enrolled in this study. Only patients with unilateral single-level (L4-5) lumbar disc hernia were selected and operated in each group and all were operated by the same surgeon. Patients were randomized into two groups, as group B (n = 30): 15 mg 0.5% isobaric bupivacaine, or group L (n = 30): 15 mg 0.5% isobaric levobupivacaine received intrathecally. The level of sensory block dermatome, degree of motor block, intraoperative sensory and motor block characteristics, and postoperative recovery times of spinal anesthesia were evaluated. The satisfaction scores of the surgeon and patients, intraoperative hemodynamic changes, intraoperative and postoperative complications were recorded.
RESULTS: The maximum level of sensory blockade was significantly higher in the levobupivacaine group (group L 7 ± 1.63, group B 8.6 ± 1.76 thoracic dermatome, p < 0.05). There was no significant difference in the onset time of sensory (group L 6 ± 3 min, group B 9 ± 4 min) and motor (in group L 7 ± 3 min, in group B 10 ± 4 min) blockade (p > 0.05). There was no significant difference between the groups regarding duration of operation (group L 49 ± 7.3 min, group B 52 ± 8.1, p > 0.05). Recovery times of sensory (175 ± 57 min) and motor (216 ± 59 min) blockade were significantly shorter in the levobupivacaine group (p < 0.05). Mobilization was also earlier in the levobupivacaine group (339 ± 90 min, p < 0.05). Patients' satisfaction and intraoperative, postoperative complications were similar between the two groups.
CONCLUSIONS: Our results showed that block recovery time was shorter in the levobupivacaine group, this may be a disadvantage for longer operative procedures. But with proper patient selection this can be eliminated. Recovery time was shorter in levobupivacaine group. Therefore, postoperative neurological examination can be done earlier. In addition, early mobilization can be an advantage for postoperative recovery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24212478      PMCID: PMC3940785          DOI: 10.1007/s00586-013-3082-0

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  27 in total

1.  Long-term follow-up of patients who received 10,098 spinal anesthetics: failure to discover major neurological sequelae.

Authors:  R D DRIPPS; L D VANDAM
Journal:  J Am Med Assoc       Date:  1954-12-18

2.  Understanding spinal anesthesia.

Authors:  M A Gouveia; L E Imbelloni
Journal:  Acta Anaesthesiol Scand       Date:  2006-02       Impact factor: 2.105

Review 3.  Bupivacaine, levobupivacaine and ropivacaine: are they clinically different?

Authors:  Andrea Casati; Marta Putzu
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2005-06

Review 4.  Critical care in orthopedic and spine surgery.

Authors:  Daniel Nazon; Glen Abergel; Carlo M Hatem
Journal:  Crit Care Clin       Date:  2003-01       Impact factor: 3.598

5.  Levobupivacaine combined with sufentanil and epinephrine for intrathecal labor analgesia: a comparison with racemic bupivacaine.

Authors:  M P Vercauteren; G Hans; K De Decker; H A Adriaensen
Journal:  Anesth Analg       Date:  2001-10       Impact factor: 5.108

6.  A comparison of spinal isobaric levobupivacaine and racemic bupivacaine for lower abdominal and lower extremity surgery.

Authors:  Thepakorn Sathitkarnmanee; Cattleya Thongrong; Sirirat Tribuddharat; Maneerat Thananun Bn; Khochakorn Palachewa Bn; Radda Kamhom Bn
Journal:  J Med Assoc Thai       Date:  2011-06

7.  Extradural S(-)-bupivacaine: comparison with racemic RS-bupivacaine.

Authors:  C R Cox; K A Faccenda; C Gilhooly; J Bannister; N B Scott; L M Morrison
Journal:  Br J Anaesth       Date:  1998-03       Impact factor: 9.166

8.  Spinal anaesthesia for elective surgery: a comparison of hyperbaric solutions of racemic bupivacaine, levobupivacaine, and ropivacaine.

Authors:  J F Luck; P D W Fettes; J A W Wildsmith
Journal:  Br J Anaesth       Date:  2008-09-02       Impact factor: 9.166

9.  Spinal anesthesia for elective lumbar spine surgery.

Authors:  J E Tetzlaff; J A Dilger; M Kodsy; J al-Bataineh; H J Yoon; G R Bell
Journal:  J Clin Anesth       Date:  1998-12       Impact factor: 9.452

10.  Levobupivacaine for pediatric spinal anesthesia.

Authors:  Hannu Kokki; Paula Ylönen; Marja Heikkinen; Matti Reinikainen
Journal:  Anesth Analg       Date:  2004-01       Impact factor: 5.108

View more
  4 in total

1.  Comparative evaluation of anaesthetic efficacy and haemodynamic effects of a combination of isobaric bupivacaine with buprenorphine vs. isobaric levobupivacaine with buprenorphine for spinal anaesthesia - A double blinded randomised clinical trial.

Authors:  Pushpavathi Ture; Ashwini H Ramaswamy; Safiya I Shaikh; Jagadish B Alur; Ajay V Ture
Journal:  Indian J Anaesth       Date:  2019-01

2.  Intrathecal levobupivacaine versus bupivacaine for inguinal hernia surgery: a randomized controlled trial.

Authors:  Ajay Singh; Anshu Gupta; Priyankar Kumar Datta; Maitree Pandey
Journal:  Korean J Anesthesiol       Date:  2018-04-24

3.  The Influence of Different Degrees of Temperature of Intrathecal Levobupivacaine on Spinal Block Characteristics in Orthopedic Surgeries: A Prospective Randomized Study.

Authors:  Reem Abdelraouf Elsharkawy; Medhat Mikhail Messeha; Adham Abdelraouf Elgeidi
Journal:  Anesth Essays Res       Date:  2019 Jul-Sep

Review 4.  Spinal anaesthesia for ambulatory surgery.

Authors:  W Rattenberry; A Hertling; R Erskine
Journal:  BJA Educ       Date:  2019-08-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.